Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Hepatitis B Virus Reactivation with Discontinuation of Nucleoside Analogue in Patients Who Received Allogeneic Hematopoietic Stem Cell Transplantation

Reactivation of hepatitis B virus (HBV) is known to occur frequently after hematopoietic stem cell transplantation (HSCT). The reactivation can be prevented by nucleos(t)ide analogue (NA), but it is unclear how long NA should be continued. Here, we report 3 cases of HBV reactivation with discontinua...

Full description

Bibliographic Details
Main Authors: Mio Tsuruoka, Jun Inoue, Yasushi Onishi, Masashi Ninomiya, Eiji Kakazu, Tomoaki Iwata, Akitoshi Sano, Kosuke Sato, Hideo Harigae, Atsushi Masamune
Format: Article
Language:English
Published: Karger Publishers 2021-02-01
Series:Case Reports in Gastroenterology
Subjects:
hepatitis b virus reactivation
allogeneic hematopoietic stem cell transplantation
hepatitis b surface antigen seroclearance
case report
Online Access:https://www.karger.com/Article/FullText/512397

Internet

https://www.karger.com/Article/FullText/512397

Similar Items